Millipore Sigma Vibrant Logo

512585 Parathyroid Hormone 1-34, Rat

Parathyroid Hormone 1-34, Rat: のSDS（安全データシート）、CoA（試験成績書）およびCoQ（品質証明書）、カタログなど製品関連の技術資料を入手いただけます。

同義語: rPTH 1-34

View This Product on Sigma-Aldrich
512585
価格＆在庫状況を照会

概要

Replacement Information

価格＆在庫状況

カタログ番号 在庫状況包装 Qty/Pk 価格 数量
512585-100UGCN
在庫状況検索中…
—
現在国内在庫なし 現在国内在庫なし
現在国内在庫有り 
販売中止
在庫僅少
現在国内在庫あり
    Remaining : Will advise
      Remaining : Will advise
      注文対象外
      お問合せください
      Contact Customer Service

      		 樹脂ｱﾝﾌﾟﾙ 100 μg
      価格を検索中…
      価格が見つかりません
      Minimum Quantity needs to be mulitiple of
      Maximum Quantity is
      弊社照会 詳細を表示　
      値引
      ()
       
      —
      弊社照会
      		 —
      Description
      OverviewSynthetic, rat parathryroid hormone. Suitable for studies of bone metabolism and glandular disorders, characterization of specific receptor sites, and as an antigen.
      Catalogue Number512585
      Brand Family Calbiochem®
      SynonymsrPTH 1-34
      References
      ReferencesColtrera, M.D., et al. 1981. J. Biol. Chem. 256, 10555.
      Roos, B.A., et al. 1981. J. Clin. Endocrinol. Metab. 53, 709.
      Jubiz, W., et al. 1972. J. Clin. Invest. 51, 2040.
      Product Information
      CAS number98614-76-7
      FormWhite lyophilized solid
      FormulationSupplied as trifluoroacetate salt.
      Hill FormulaC₁₈₀H₂₉₁N₅₅O₄₈S₂
      Chemical formulaC₁₈₀H₂₉₁N₅₅O₄₈S₂
      Quality LevelMQ100
      Applications
      Biological Information
      Purity≥97% by HPLC
      Physicochemical Information
      Peptide SequenceH-Ala-Val-Ser-Glu-Ile-Gln-Leu-Met-His-Asn-Leu-Gly-Lys-His-Leu-Ala-Ser-Val-Glu-Arg-Met-Gly-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Phe-OH
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Standard Handling
      Storage -20°C
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 1 month at -20°C.
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      カタログ番号 GTIN
      512585-100UGCN 04055977272055

      Documentation

      Parathyroid Hormone 1-34, Rat (M)SDS

      タイトル

      英語版製品安全データシート（(M)SDS） 

      Parathyroid Hormone 1-34, Rat 試験成績書（CoA）

      タイトルロット番号
      512585

      参考資料

      参考資料の概要
      Coltrera, M.D., et al. 1981. J. Biol. Chem. 256, 10555.
      Roos, B.A., et al. 1981. J. Clin. Endocrinol. Metab. 53, 709.
      Jubiz, W., et al. 1972. J. Clin. Invest. 51, 2040.
      データシート

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision16-May-2008 RFH
      SynonymsrPTH 1-34
      DescriptionSynthetic, rat parathryroid hormone. Suitable for studies of bone metabolism and glandular disorders, characterization of specific receptor sites, and as an antigen.
      FormWhite lyophilized solid
      FormulationSupplied as trifluoroacetate salt.
      CAS number98614-76-7
      Chemical formulaC₁₈₀H₂₉₁N₅₅O₄₈S₂
      Peptide SequenceH-Ala-Val-Ser-Glu-Ile-Gln-Leu-Met-His-Asn-Leu-Gly-Lys-His-Leu-Ala-Ser-Val-Glu-Arg-Met-Gly-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Phe-OH
      Purity≥97% by HPLC
      SolubilityDMSO (1 mg/ml) or 5% acetic acid (1 mg/ml)
      Storage -20°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 1 month at -20°C.
      Toxicity Standard Handling
      Merck USA index14, 7034
      ReferencesColtrera, M.D., et al. 1981. J. Biol. Chem. 256, 10555.
      Roos, B.A., et al. 1981. J. Clin. Endocrinol. Metab. 53, 709.
      Jubiz, W., et al. 1972. J. Clin. Invest. 51, 2040.